What are West Pharmaceutical Services's profit margins?

West Pharmaceutical Services (WST) runs a 36.3% gross margin and a 20.3% operating margin, with a 16.8% net margin.

Where do West Pharmaceutical Services's ratios come from?

Every ratio is computed from West Pharmaceutical Services's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

West Pharmaceutical Services WST Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	143%+3.4pp	141.3%-0.9pp	139.9%-6.1pp	139.2%-10.0pp	139.6%-12.0pp
Operating margin	78.5%-0.6pp	77.3%-4.7pp	78%-7.2pp	78.3%-9.0pp	79.1%-10.6pp
Net margin	65.7%-3.1pp	65%-7.1pp	65.9%-9.2pp	67%-9.9pp	68.8%-8.0pp
EBITDA margin	100.4%+0.3pp	99.2%-3.0pp	99.7%-4.9pp	99.8%-6.2pp	100.1%-7.6pp
Free cash flow margin	53.7%+9.9pp	50%+3.7pp	44.3%-6.5pp	43%-11.0pp	43.7%-11.7pp
Returns
Return on equity	70.6%-2.0pp	68.9%-7.1pp	69.8%-9.9pp	70.6%-12.2pp	72.6%-10.6pp
Return on assets	52.3%-2.0pp	51.2%-5.7pp	51.9%-7.7pp	52.7%-9.3pp	54.2%-7.8pp
Return on invested capital	72.5%-4.6pp	71.1%-11.5pp	72.4%-16.0pp	74.2%-19.4pp	77.1%-20.7pp
Efficiency
Asset turnover	3.2×0.0×	3.2×0.0×	3.1×0.0×	3.1×-0.1×	3.2×-0.1×
Inventory turnover	18.9×+0.8×	18.6×+1.0×	18.5×+1.3×	18.4×+1.3×	18.1×+1.2×
Liquidity
Current ratio	11.4×+0.5×	11.4×+0.7×	11.2×+0.4×	11.3×-0.2×	10.9×-1.9×
Quick ratio	8.6×+0.6×	8.6×+0.7×	8.4×+0.3×	8.4×-0.3×	8×-1.8×
Cash ratio	3.8×+0.5×	3.8×+0.3×	3.5×-0.4×	3.4×-1.1×	3.3×-2.1×
Leverage
Debt-to-equity	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.5×0.0×
Debt-to-assets	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.3×0.0×
Net debt / EBITDA	-1.6×-0.7×	-1.5×-0.4×	-1.1×+0.4×	-0.9×+1.1×	-0.8×+1.6×
Per Share
Book value per share	$167.42+15.0%	$162.87+12.4%	$155.58+6.0%	$151.05+2.5%	$145.61-2.2%
Valuation
Market capitalization	$72.72B-15.5%	$70.84B-28.4%	$74.77B-26.2%	$77.82B-27.5%	$86.03B-22.8%
Enterprise value	$71.53B-16.3%	$69.75B-28.9%	$73.97B-26.1%	$77.16B-27.0%	$85.44B-22.0%
Price / earnings	144.6×-28.2×	145.9×-43.4×	154×-31.1×	159.5×-31.6×	172.8×-27.0×
Price / sales	23.7×-6.1×	23.7×-10.5×	25.4×-9.4×	26.8×-9.9×	29.8×-8.4×
Price / book	23.9×-8.3×	23.9×-13.1×	26.5×-10.7×	28.3×-10.7×	32.2×-7.7×
EV / EBITDA	93×-25.2×	94.1×-38.4×	101×-30.5×	106.5×-30.1×	118.2×-21.4×
EV / sales	23.3×-6.3×	23.3×-10.6×	25.2×-9.2×	26.6×-9.6×	29.6×-7.9×
Free cash flow yield	9.1%+3.1pp	8.4%+3.0pp	7.2%+1.4pp	6.7%+0.8pp	6%+0.2pp
Earnings yield	11.2%+1.7pp	11%+2.6pp	10.6%+1.9pp	10.3%+1.9pp	9.4%+1.4pp
Dividend yield	1.3%+0.2pp	1.4%+0.4pp	1.3%+0.4pp	1.3%+0.4pp	1.1%+0.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about West Pharmaceutical Services.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are West Pharmaceutical Services's profit margins?: West Pharmaceutical Services (WST) runs a 36.3% gross margin and a 20.3% operating margin, with a 16.8% net margin.
Where do West Pharmaceutical Services's ratios come from?: Every ratio is computed from West Pharmaceutical Services's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.